MapLight Therapeutics, Inc. (MPLT): Insider Trades and Fund Holdings
In the past 12 months, MapLight Therapeutics, Inc. insiders reported 1 open-market purchase worth $50.1M and 7 sales worth $1.26M; 1 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.
- Oct 15, 2026Insider saleCEO Christopher A. Kroeger sold $595,423
- Oct 15, 2026Insider saleChief Medical Officer Erin Pennock Foff sold $124,068
- Oct 15, 2026Insider saleChief Discovery Officer Anatol Kreitzer sold $96,024
- Oct 15, 2026Insider saleChief Scientific Officer James Woodruff Lillie sold $93,025
- Oct 15, 2026Insider saleCFO Jonathan Gillis sold $82,149
- Oct 15, 2026Insider saleGeneral Counsel Kristopher Hanson sold $72,882
- Oct 15, 2026Planned saleKroeger Christopher A. (officer) filed notice to sell about $575,527 around Oct 15, 2026
- Oct 15, 2026Planned saleFoff Erin Pennock (officer) filed notice to sell about $119,923 around Oct 15, 2026
- Oct 15, 2026Planned saleROBERT MALENKA (director) filed notice to sell about $115,658 around Oct 15, 2026
- Oct 15, 2026Planned saleAnatol Kreitzer (officer) filed notice to sell about $97,625 around Oct 15, 2026
- Oct 15, 2026Planned saleLillie James Woodruff (officer) filed notice to sell about $89,917 around Oct 15, 2026
- Oct 15, 2026Planned saleGILLIS JONATHAN (officer) filed notice to sell about $79,404 around Oct 15, 2026
- Oct 15, 2026Planned saleHanson Kristopher (officer) filed notice to sell about $70,446 around Oct 15, 2026
- Sep 16, 2026Insider saleGeneral Counsel Kristopher Hanson sold $192,660 under a 10b5-1 plan
- Sep 16, 2026Planned saleHanson Kristopher (officer) filed notice to sell about $199,429 around Sep 16, 2026
- Aug 14, 2026Insider buy10% owner Catalyst4, Inc. bought $50.1 million
- Jun 30, 2026FundRenaissance Technologies opened a position in Q2 2026 (13F filed Aug 13, 2026)
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 16 | Christopher A. KroegerCEO | ▼ SELL | $595K |
| Oct 16 | Erin Pennock FoffChief Medical Officer | ▼ SELL | $124K |
| Oct 16 | Anatol KreitzerChief Discovery Officer | ▼ SELL | $96K |
| Oct 16 | James Woodruff LillieChief Scientific Officer | ▼ SELL | $93K |
| Oct 16 | Jonathan GillisCFO | ▼ SELL | $82K |
| Oct 16 | Kristopher HansonGeneral Counsel | ▼ SELL | $73K |
| Sep 18 | Kristopher HansonGeneral Counsel | ▼ SELL10b5-1 | $193K |
| Aug 18 | Catalyst4, Inc.10% owner | ▲ BUY | $50.1M |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Christopher A. Kroeger | CEO | 0 | $0 | 1 | $595K |
| Erin Pennock Foff | Chief Medical Officer | 0 | $0 | 1 | $124K |
| Anatol Kreitzer | Chief Discovery Officer | 0 | $0 | 1 | $96K |
| James Woodruff Lillie | Chief Scientific Officer | 0 | $0 | 1 | $93K |
| Jonathan Gillis | CFO | 0 | $0 | 1 | $82K |
| Kristopher Hanson | General Counsel | 0 | $0 | 2 | $266K |
| Catalyst4, Inc. | 10% owner | 1 | $50.1M | 0 | $0 |
Tracked funds that report MPLT
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 6,937 | $249K | ▲ New |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →